MYCN-dependent Transcription Termination and Stress Resilience of Transcription
MYCN-dependent Transcription Termination and Stress Resilience of Transcription
批准号:
438596161
负责人:
Professor Dr. Martin Eilers
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:
中文摘要
MYCN是MYC家族的三个基因之一,并且是许多神经内分泌肿瘤实体中的驱动癌基因。它编码一种核蛋白,该核蛋白显示出转录因子的许多特征,并与活性启动子和许多增强子全局结合。一致的是,大量文献证明MYCN与其对应物MYC一样,可以积极和消极地影响许多基因的表达,并可能提高整体转录率。然而,很难解释MYC和MYCN在其靶基因表达变化方面在肿瘤发生中的普遍作用,因为这两种蛋白质对具有MYC/MYCN结合启动子的绝大多数基因的表达没有影响或充其量非常弱。因此,没有共识模型的致癌功能的MYC蛋白已经emerged.We最近确定了MYCN相互作用组,并研究了其在细胞周期中的动力学,这表明MYCN蛋白协调转录延长与DNA复制。我们还发现,如果RNA聚合酶II(RNAPII)停滞,MYCN可以促进过早的转录终止。我们未发表的工作确定了EXOSC 10,一种3 '-5'-RNA核酸外切酶,作为一种与MYCN和RNAPII形成三元复合物的蛋白质,并可能使MYCN能够促进停止RNAPII的重新启动。我们从这些发现推测,MYCN特异性地协调转录与DNA复制和双链断裂修复,并且如果RNAPII由于转录诱导的扭转应力以及核苷酸不平衡而停滞,则促进启动子的清除。我们假设终止转录和清除启动子使RNAPII停滞的能力是MYCN依赖性致癌转化的核心,因为它增强了肿瘤细胞中转录的应激恢复力。这项资助的目的是探索潜在的机制并验证这一假设。
英文摘要
MYCN is one of three genes of the MYC family and a driving oncogene in many neuroendocrine tumor entities. It encodes a nuclear protein that displays many features of a transcription factor and binds globally to active promoters and many enhancers. Consistently, a large body of literature documents that MYCN, like its counterpart MYC, can both positively and negatively affect the expression of many genes and potentially enhance global transcription rates. It has been difficult, however, to explain the pervasive role of MYC and MYCN in tumorigenesis in terms of changes in expression of its target genes since both proteins have either no or at best very weak effects on expression of the vast majority of genes with MYC/MYCN-bound promoters. As consequence, no consensus model of oncogenic functions of MYC proteins has emerged.We have recently identified the MYCN interactome and studied its dynamics during the cell cycle; this suggested that MYCN proteins co-ordinate transcription elongation with DNA replication. We also found that MYCN can promote premature transcription termination if RNA Polymerase II (RNAPII) stalls. Our unpublished work identifies EXOSC10, a 3'-5´-RNA exonuclease, as a protein that forms a ternary complex with MYCN and RNAPII and may enable MYCN to promote the restart of stalling RNAPII. We speculate from these findings that MYCN specifically coordinates transcription with DNA replication and double-strand break repair and facilitates clearance of promoters if RNAPII stalls due to transcription-induced torsional stress as well as nucleotide imbalances. We hypothesize that the ability to terminate transcription and clear promoters from stalling RNAPII is central to MYCN-dependent oncogenic transformation since it enhances the stress resilience of transcription in tumor cells. The aim of this grant is to explore the underlying mechanisms and test this hypothesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting MYC-driven hepatocellular carcinoma via Aurora-A ligands
-
批准号:409494652
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
ShRNA Screening and Histopathology
-
批准号:280454646
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Targeting MYC in pancreatic cancer
-
批准号:280452953
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Systematic shRNA screens for the analysis of critical signaling pathways in KRAS-mutant multiple myeloma
-
批准号:242271643
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Myc-dependent apoptosis as a tumor-suppressive mechanism: how do cells discriminate between physiological and oncogenic levels of Myc expression?
-
批准号:244461114
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Systemic shRNA screens and high throughout sequencing to investigate pathway dependence in multiple myeloma
-
批准号:144856378
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Systematic shRNA and siRNA screens to investigate drug resistance in human leukemia
-
批准号:81569355
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Role of Miz1 in the Atr/Chk1 signalling pathway and in Myc-induced apoptosis
-
批准号:5422428
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2004
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Rolle des Zink-Finger-Proteins Miz-1 in der Tumorigenese und in der Kontrolle der Proliferation von Keratinozyten und Lymphozyten
-
批准号:5340710
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2001
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Regulation of the cdk inhibitor, p27 Regulation des cdk inhibitor, p27
-
批准号:5224632
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:1995
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
Multimerization of MYC proteins as oncogenic principle
-
批准号:521472328
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Martin Eilers
-
依托单位:
国内基金
海外基金
登录
查看更多内容
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
-
批准号:82371585
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:周鲁明
-
依托单位:
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
-
批准号:82371660
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:魏喆
-
依托单位:
当归芍药散基于双向调控Ras/cAMP-dependent PKA自噬通路的“酸甘化阴、辛甘化阳”的药性基础
-
批准号:81973497
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:刘四军
-
依托单位:
CDK5调节羊驼黑色素生成的作用研究
-
批准号:31201868
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:范瑞文
-
依托单位:
蒺藜苜蓿细胞周期蛋白依赖性激酶(cyclin-dependent kinase)对根瘤发育的功能研究
-
批准号:31100871
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2011
-
负责人:何恒斌
-
依托单位:
铁磁、半金属-超导异质结中电子输运的理论研究
-
批准号:60971053
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2009
-
负责人:周世平
-
依托单位:
Riesz乘积和树上的分枝测度的重分形分析
-
批准号:10826054
-
项目类别:数学天元基金项目
-
资助金额:3.0万元
-
批准年份:2008
-
负责人:章雄鹰
-
依托单位:
CaMK II信号转导通路参与前扣带回皮质调节IBS大鼠的内脏痛觉
-
批准号:30800512
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:曹芝君
-
依托单位:
Posphoinositide-dependent kinase-1在肿瘤细胞趋化运动和转移中的作用机制
-
批准号:30772529
-
项目类别:面上项目
-
资助金额:29.0万元
-
批准年份:2007
-
负责人:张宁
-
依托单位: